Here is the rundown on market activity for DexCom, Inc. (NASDAQ:DXCM). Steven Robert Pacelli, EVP reported the sale of 10,300 shares. The shares were purchased at an average price of $94.00. Pacelli now owns $12,314,846 of the stock according to the SEC filing. Andrew K. Balo, EVP, Clinical and Regulatory sold $464,350 worth of shares at an average price of $92.87 on Wed the 21st. That brings Balo’s holdings to $10,804,682 as reported to the SEC.
Kevin R. Sayer, President & CEO disclosed the sale of 7,000 shares of DXCM stock. The shares were sold on September 14th for an average price of $91.79. The President & CEO now owns $28,169,525 of the stock per the Form 4 SEC filing.
These funds have also shifted positions in (DXCM). As of quarter end Macquarie Group Ltd had bought a total of 83,185 shares growing its position 60.2%. The value of the investment in DexCom, Inc. went from $9,382,000 to $17,559,000 a change of $8,177,000 since the last quarter. As of the end of the quarter Twin Tree Management, Lp had disposed of 300 shares trimming its holdings by 10.0%. The value of the company’s investment in DexCom, Inc. increased from $204,000 to $221,000 a change of 8.3% quarter over quarter.
Northwestern Mutual Wealth Management Co grew its ownership by buying 37 shares an increase of 18.9% from 03/31/2016 to 06/30/2016. Northwestern Mutual Wealth Management Co claims 233 shares with a value of $18,000. The total value of its holdings increased 38.5%. Royal Bank Of Canada expanded its position by buying 109 shares an increase of 9.8% as of 06/30/2016. Royal Bank Of Canada now controls 1,226 shares valued at $97,000. The value of the position overall is up by 27.6%.
Equity analyst B. Riley added DXCM to its research portfolio with a rating of “Neutral” and setting a price target of $97.00. On September 16 the company was set at “Buy” by Desjardins which was a boost from the previous “” rating.
On September 14 the stock rating was downgraded to “Neutral” from “Buy” by analysts at BTIG Research. On April 14, 2016 BTIG Research started covering DXCM giving it an initial rating of “Buy” and projecting a price target of $80.00.
On February 24 JP Morgan kept the company rating at “Overweight” but lowered the price expectation to $100.00 from $120.00. February 24 investment analysts at Jefferies made no change to the stock rating of “Buy” and lowered the price expectation from $100.00 to $90.00.
The company is trading up by 0.60% since yesterday’s close of $93.16. Shares are trading at $93.72 marginally over the 50 day moving average which is $92.13 and which is just a bit higher than the 200 day moving average of $76.75. The 50 day moving average went up $1.59 or +1.72% and the 200 day average moved up $16.97.
As of the latest earnings report the EPS was $-0.98 and is expected to be $-0.57 for the current year with 83,883,000 shares outstanding. Next quarter’s EPS is expected be $0.03 with next year’s EPS projected to be $0.25.
Traders are a little more bearish recently if you evaluate the motion in short interest. The company realized a rise in short interest between August 31, 2016 and September 15, 2016 of 0.11%. Short interest grew from 4,371,574 to 4,831,956 over that timeframe. With short interest at 4,831,956 and short average daily volume at 680,795, the short-interest ratio is 7.1 and the short interest percentage is 0.06% as of September 15.